Literature DB >> 3675283

Cysts of Tenon's capsule following filtration surgery. Medical management.

M B Sherwood1, G L Spaeth, S T Simmons, D A Nichols, A M Walsh, W C Steinmann, R P Wilson.   

Abstract

Cysts of Tenon's capsule (encapsulated blebs) developed postoperatively in 77 (13%) of 607 eyes that underwent filtration surgery between 1980 and mid-1985. The annual incidence was not uniform, increasing markedly throughout the period. Seventy-four eyes were treated with medical therapy only. At a mean follow-up of 19 months, the success rate for these eyes, defined as an intraocular pressure (IOP) of 21 mm Hg or less, was 92%. The three eyes that underwent surgical revision subsequently failed clinically by the study criteria. Those patients in whom cysts of Tenon's capsule developed were compared with an age-matched control group to assess for possible differences in long-term outcome. There was a significantly higher IOP in the Tenon's cyst group at one and three months after surgery, and an increased proportion of IOPs above 30 and 40 mm Hg. At a six-month and later follow-up, there was no significant difference in the mean IOP or in progression of visual field loss. Causative factors were sought for the development of these cysts of Tenon's capsule. Prior conjunctival surgery, or previous cyst formation in the other eye, were the significant risk factors noted.

Entities:  

Mesh:

Year:  1987        PMID: 3675283     DOI: 10.1001/archopht.1987.01060110063032

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  9 in total

1.  Viscocanalostomy versus trabeculectomy in patients with bilateral high-tension glaucoma.

Authors:  Alper Yarangümeli; Serkan Güreser; Ozlem Gürbüz Köz; Atilla Halil Elhan; Gülcan Kural
Journal:  Int Ophthalmol       Date:  2005-09-29       Impact factor: 2.031

Review 2.  Needling for encapsulated trabeculectomy filtering blebs.

Authors:  Andrew Feyi-Waboso; Henry O D Ejere
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

3.  Long-term outcome of mitomycin C-augmented needle revision of trabeculectomy blebs for late trabeculectomy failure.

Authors:  S Lin; D Byles; M Smith
Journal:  Eye (Lond)       Date:  2018-08-29       Impact factor: 3.775

4.  Anti-inflammatory fibrosis suppression in threatened trabeculectomy bleb failure produces good long term control of intraocular pressure without risk of sight threatening complications.

Authors:  J R Fuller; T H Bevin; A C B Molteno; B J T Vote; P Herbison
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

Review 5.  Management of complications in glaucoma surgery.

Authors:  Lingam Vijaya; Panday Manish; George Ronnie; B Shantha
Journal:  Indian J Ophthalmol       Date:  2011-01       Impact factor: 1.848

6.  Revision of encapsulated blebs after trabeculectomy: Long-term comparison of standard bleb needling and modified needling procedure combined with transconjunctival scleral flap sutures.

Authors:  P Laspas; P D Culmann; F H Grus; V Prokosch-Willing; A Poplawksi; N Pfeiffer; E M Hoffmann
Journal:  PLoS One       Date:  2017-05-18       Impact factor: 3.240

7.  Early transconjunctival needling revision with 5-fluorouracil versus medical treatment in encapsulated blebs: a 12-month prospective study.

Authors:  Ricardo Suzuki; Remo Susanna
Journal:  Clinics (Sao Paulo)       Date:  2013-10       Impact factor: 2.365

8.  A New Method for Revision of Encapsulated Blebs after Trabeculectomy: Combination of Standard Bleb Needling with Transconjunctival Scleral Flap Sutures Prevents Early Postoperative Hypotony.

Authors:  Panagiotis Laspas; Philipp David Culmann; Franz Hermann Grus; Verena Prokosch-Willing; Alicia Poplawksi; Norbert Pfeiffer; Esther Maria Hoffmann
Journal:  PLoS One       Date:  2016-06-17       Impact factor: 3.240

9.  Objective documentation of anterior chamber depth following trabeculectomy and its correlation with intraocular pressure and bleb functionality.

Authors:  Andreas Diagourtas; Dimitrios Papaconstantinou; Athanasios Vergados; Konstantinos Andreanos; Chryssanthi Koutsandrea
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.